💨 Abstract
Biotech firm MediWound Ltd. reported a Q2 loss of $13.3 million, or $1.23 per share, missing analyst expectations of a loss of 55 cents per share. However, the company's revenue of $5.7 million beat the forecasted $5.6 million. MediWound specializes in treatments for burns and hard-to-heal wounds.
Courtesy: WTOP Staff
Suggested
U.S. applications for jobless benefits dip to 224,000 and stay within the historically low range of recent years. -
Trump’s nod to Europe on a future peace force for Ukraine vastly improves its chances of success -
U.S. producer prices surge in July as Trump tariffs push costs higher -
The Latest: Federal agents will patrol Washington 24/7 -
US applications for jobless benefits fell last week and remain in historically healthy range -
Esta es la mejor ciudad del mundo para los veinteañeros, según Time Out -
The Taliban will shower Kabul with flowers from helicopters for their takeover anniversary -
Real Madrid signs Argentine teenager Franco Mastantuono to a six-year deal -
Lifeward: Q2 Earnings Snapshot -
Ten Hag says he can’t work Harry Potter-style magic to hasten Leverkusen rebuild -